Rivaroxaban e malattia renale cronica: evidenze dal presente e prospettive future
Cardiovascular diseases represent the main cause of comorbidly in chronic kidney disease (CKD) patients, with a 7% incidence in atrial fibrillation (AF) in end-stage renal disease (ESRD) patients. Until recently, prophylactic treatment of atrial fibrillation complications (such as thromboembolism)...
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | Italian |
| Published: |
AboutScience Srl
2019-03-01
|
| Series: | Giornale di Clinica Nefrologia e Dialisi |
| Online Access: | https://journals.aboutscience.eu/index.php/gcnd/article/view/507 |